EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS TH INTERNATIONAL PROSTATE CANCER AND UROLOGIC ONCOLOGY SYMPOSIUM NOVEMBER 7-9, 2019 NEW YORK, NY MOUNTSINAIUROLOGYCME.ORG HIGHLIGHTS • Over 100 world-renowned faculty • Engaging point-counterpoint debates and • Live 3-D surgical demonstrations, including panel discussion prostate, kidney, bladder procedures • Global exposure with international web streaming of select sessions and events Welcome to the Fourth International Prostate Cancer and Urologic Oncology Symposium. EDUCATIONAL HIGHLIGHTS • Live 3-D surgery transmission covering complex urologic surgery • Comprehensive didactic lectures from the world’s leading experts in urologic oncology • Robust review of the latest advances in surgical techniques and management of prostate, kidney, and bladder cancer • Personal interaction with world-class faculty • Stimulating point-counterpoint debates on timely topics DAILY HIGHLIGHTS PROSTATE DAY 1 THUR. 11/7/19 PROSTATE DAY 2 FRI. 11/8/19 KIDNEY & BLADDER SAT. 11/9/19 • Advanced imaging in genomics • Innovations in the management of • New progress in pre-operative and for prostate cancer castrate-sensitive prostate cancer intra-operative imaging, 3-D • Biomarkers and immunotherapy modelling, and ultra sound • Focus on radiomics and guidance for renal tumors radiogenomics • Update on clinical trials for castrate-resistant treatments for • Novel therapeutics in the • Utility of imaging and artificial prostate cancer management of metastatic renal intelligence in prostate cancer cell carcinomas: VEFG, TKIs, and treatment • Advances in multi-modal immunotherapy treatments for locally advanced • Targeted biopsy and focal therapy prostate cancer • Genomics and biomarkers for options for prostate cancer kidney and bladder cancer • 3-D robotic technique for nerve • Urinary incontinence and sexual sparing • Advances in second line function post-operative treatment transitional cell carcinoma for • Status of bio tech and clinical trials bladder and kidney • Improvements in imaging and in prostate cancer treatment targeted therapy for metastatic • Improvement in surgical technique cancer • Highlights from ASCO and AUA on to maximize outcome for kidney metastatic prostate cancer and bladder cancer • New techniques to improve out- comes for robotic prostatectomy • Discussion of single port robotic surgery • Clinical trials in nerve sparing and nerve regeneration after prostate cancer surgeries A full agenda will be available on our symposium website shortly. A full agendPlease a will feel be free available to reference shortly. the Please 2018 agenda feel free on to pages reference 10-20, last year’s which willagenda be similar on pages to the 10-20.2019 program. 2 | MOUNTSINAIUROLOGYCME.ORG NOVEMBER 7 – 9, 2019 NEW YORK, NY EXHIBITOR & PROMOTIONAL PARTNERSHIP PROSPECTUS DIRECTOR: ASH TEWARI, MBBS, MCH, FRCS (Hon.) Professor and Chairman of the Department INVITATION of Urology Department of Urology TO EXHIBIT/SPONSOR [email protected] CO-DIRECTOR: Dear Industry Colleagues: KETAN BADANI, MD Professor of Urology and Vice Chairman of the Department of Urology On behalf of the Department of Urology at the Icahn School of Medicine at Mount Department of Urology Sinai in New York City, I am thrilled to invite you to participate in the Fourth [email protected] International Prostate Cancer and Urologic Oncology Symposium set for November 7-9, 2019 in New York! This year’s program is our most innovative yet, PLANNING COMMITTEE: complete with over 100 world-renowned experts who will provide in-depth training NINA BHARDWAJ, MD, PhD on cutting-edge medical advances and ground-breaking treatment approaches for Professor of Medicine, Hematology, prostate, kidney, bladder, and renal cell cancers. There will also be a unique focus this and Medical Oncology Department of Medicine, Hematology, and year on critical issues in immuno-oncology and sexual health, as well as multiple live Medical Oncology surgeries and focused demonstrations. Ranked among the nation’s best for Urology [email protected] in the “Best Hospitals” issue of U.S. News & World Report, the physicians of Mount Sinai Urology are leaders in robotic surgery and minimally invasive procedures to CARLOS CORDON-CARDO, MD, PhD Professor and Chairman treat prostate, kidney, and bladder cancers. Join the Mount Sinai Department of of the Department of Pathology Urology for an interactive symposium with 3-D demonstrations of the latest robotic Department of Pathology surgery techniques for prostate, kidney and bladder cancer. Directed by the world’s [email protected] leading robotic experts and taught by an internationally renowned faculty, attendees MATTHEW GALSKY, MD gain emerging and practical tools to optimize their robotic surgery skills. We are Professor of Medicine, Hematology, and Medical Oncology also on the forefront of diagnosis and treatment for urinary tract conditions, kidney Department of Medicine, Hematology, and stones, infertility, erectile dysfunction, female pelvic medicine, and pediatric urologic Medical Oncology conditions. [email protected] As you will see in the enclosed Partnership Prospectus, we are offering several MANTU GUPTA, MD, FRCS (Glasg) Professor of Urology sponsorship and exhibitor opportunities for this year’s program, to help you gain Department of Urology access to, and inform, symposium attendees about your company, your research [email protected] development program and your marketed products. We expect over 500 attendees ADAM MARGOLIN, PhD at this year’s program, including physicians, nurses, pharmacists, and researchers, all Professor and Chairman of whom will be actively engaged in discussions across the prostate and urological of the Department of Genetics and Genomic Science cancer landscape. Department of Genetics and Genomic Science Affiliating with the Fourth International Prostate Cancer and Urologic Oncology [email protected] Symposium is the most direct route in meeting and sharing your products with some WILLIAM OH, MD of the most well-known, respected health care providers and decision makers in the Professor of Medicine, Hematology, urologic community. As an essential part of the symposium, you will be able to make and Medical Oncology invaluable connections with key opinion leaders, academic researchers and other Department of Medicine, Hematology, and Medical Oncology industry stakeholders as we continue the tradition of advancing the level of science [email protected] and quality of care in prostate and urologic oncology. MICHAEL PALESE, MD To this end, I invite you to review the attached Partnership Prospectus to learn Professor of Urology more about the program and to find out how to reserve your prime exhibit space Department of Urology today. More information can be found at mountsinaiurologycme.org. If you have [email protected] any questions, please contact Ms. Jennifer Berens at 425-442-13140 or via email at ERIC SCHADT, PhD Dean of Precision Medicine, Professor of [email protected]. We look forward to having you as our industry partner Genetics and Genomic Science for this year’s program! Department of Genetics and Genomic Science Sincerely, [email protected] BACHIR TAOULI, MD Professor of Radiology Department of Radiology [email protected] Ash Tewari, MBBS, MCh, FRCS (Hon.) Professor, Icahn School of Medicine at Mount Sinai Kyung Hyun Kim, MD, Chair of the Department of Urology Chair, Milton and Carroll Petrie Department of Urology, Mount Sinai Health System MOUNTSINAIUROLOGYCME.ORG | 3 • 2017 •• 2018 ••• FACULTY Ronney Abaza MD, FACS Ohio Health Dublin Alexander Haese MD Martini-Clinic Prostate Vipul Patel MD, FACS Florida Hospital Cancer Methodist Hospital Cancer Center, Hamburg, Germany Institute Urologic Oncology Program Mutahar Ahmed MD Hackensack University Misop Han MD Johns Hopkins School of Peter Pinto MD National Cancer Institute Medical Center, New Jersey Center for Medicine Urologic Oncology Branch Prostate Cancer & Urology Stefanie Hectors PhD Mount Sinai - Icahn Francesco Porpiglia MD San Luigi Gonzaga Olof Akre MD Mount Sinai - Department School of Medicine Hospital, University of Turin of Urology/Karolinska Institutet Ashok Hemal MD Wake Forest Baptist Health - James Porter MD Swedish Urology Group Walter Artibani MD University Hospital Institute for Regenerative Medicine Isaac Powell MD Wayne State University Verona, Italy Michael Herman MD South Nassau Surgical Sciences Ketan Badani MD Mount Sinai - Department Communities Hospital Rajveer Purohit MD Mount Sinai -Department of Urology Markus Hohenfellner MD University Hospital of Urology Mitchell C. Benson MD Columbia University Heidelberg Department of Urology Ganesh Raj MD, PhD UT Southwestern Medical Medical Center Jim Hu MD, MPH Weill Cornell Medicine Center Department of Urology Thomas Bessede MD CHU Bicetre, Bicetre Simon Hughes PhD King’s College London Abhay Rane OBE, MS, FRCS, FRCS (Urol) East Surrey Pari-South University John Isaacs PhD Johns Hopkins School of Hospital, United Kingdom Jerry Blaivas MD Mount Sinai - Department Medicine Art Rastinehad DO Mount Sinai - Department of Urology Jihad Kaouk MD Cleveland Clinic - Department of Urology Maurizio Buscarini MD Universita Campus of Urology Amanda Rhee MD Mount Sinai - Department Bio-Medico di Roma Steven Kaplan MD Mount Sinai - Department of Anesthesiology, Perioperative & Pain Umberto Capitanio MD San Raffaele Hospital of Urology Medicine Milan, Italy Deepak